Collegium Pharmaceutical Inc
F:354
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Collegium Pharmaceutical Inc (354) under the Base Case is 57.85 EUR per share.
Compared with the current market price of 22.6 EUR, the stock appears
Undervalued by 61% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Collegium Pharmaceutical Does
Collegium Pharmaceutical makes prescription medicines for pain management and related conditions. Its main product portfolio centers on branded therapies that doctors prescribe to patients who need longer-lasting pain control, especially in settings where other treatments have not worked well or are not appropriate. The company focuses on a narrow set of medicines rather than a broad drug catalog.
- Headquarters
- United States of America US
- Employees
- 423
- IPO date
- May 7, 2015
Continue Research
Decided on Collegium Pharmaceutical? Get an email when Collegium Pharmaceutical Inc reaches the price you’d buy at. Free with an account.
Other Collegium Pharmaceutical listings
What is the Intrinsic Value of one Collegium Pharmaceutical Inc stock?
The intrinsic value for
Collegium Pharmaceutical Inc (354) under the Base Case is 57.85 EUR.
Is Collegium Pharmaceutical Inc stock undervalued or overvalued?
Compared with the current market price of 22.6 EUR, the stock appears Undervalued by 61% .